Literature DB >> 30321085

Taurine and aneurysmal subarachnoid hemorrhage prognosis.

Iván Pérez-Neri1, Carlos Eduardo Diéguez-Campa2.   

Abstract

Despite its beneficial effects for the cardiovascular system, taurine remains a controversial substance. Taurine increases cardiac muscle strength and prevents arrhythmias, but its benefits go beyond this. Determining taurine levels may become an issue of life or death. In aneurysmal subarachnoid hemorrhage, taurine may be a warning signal informing of the risk of death in a patient. High plasma taurine levels may identify those patients at a high risk for death or a vegetative state at discharge from the hospital; thus, taurine may be a vital marker for the prognosis of this disorder. This is even more relevant considering that the result occurred in patients with a good neurological grade at admission that would usually receive a good prognosis but, despite this, one out of four died or remained in a vegetative state. Maybe taurine is key to explain this apparent paradox.

Entities:  

Keywords:  Aneurysm; hemorrhage; outcome; prognosis; taurine; vasospasm

Mesh:

Substances:

Year:  2018        PMID: 30321085     DOI: 10.1080/00325481.2018.1533382

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  2 in total

1.  Association between dietary acid load and cancer risk and prognosis: An updated systematic review and meta-analysis of observational studies.

Authors:  Ran Wang; Zhao-Yan Wen; Fang-Hua Liu; Yi-Fan Wei; He-Li Xu; Ming-Li Sun; Yu-Hong Zhao; Ting-Ting Gong; Hui-Han Wang; Qi-Jun Wu
Journal:  Front Nutr       Date:  2022-07-27

2.  Association of Taurine with In-Hospital Mortality in Patients after Out-of-Hospital Cardiac Arrest: Results from the Prospective, Observational COMMUNICATE Study.

Authors:  Naemi Herzog; Rahel Laager; Emanuel Thommen; Madlaina Widmer; Alessia M Vincent; Annalena Keller; Christoph Becker; Katharina Beck; Sebastian Perrig; Luca Bernasconi; Peter Neyer; Stephan Marsch; Philipp Schuetz; Raoul Sutter; Kai Tisljar; Sabina Hunziker
Journal:  J Clin Med       Date:  2020-05-09       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.